Nanotechnology approach in tuberculosis

Nanotechnology is duplicating matter on an atomic scale. Nanotechnology refers to the construction of the structure at the micro level. The development of new drugs decreases resistance and drug interaction. In recent years, much research has been done on the development of nanotechnology-based therapy to replace the administration of antibiotics. Different animal models are tired of developing antibiotics with polymer technologyNanoparticles are made of biocompatible and biodegradable materials that are natural or synthetic. They can easily dissolve in cells. Polymeric nanoparticles represent as bioadhesives in the gastrointestinal tract. Polylactic-co-glycolic acid [PLGA] is a copolymer accepted by the administration of food and medication for therapeutic purposes. Nano beads have a slow and sustained release of particles. The introduction of nanoparticles allows to reduce side effects, several drugs can be encapsulated in a matrix, of high constancy.


    Related Conference of Nanotechnology approach in tuberculosis

    March 13-14, 2025

    9th International Conference on Rare Diseases

    Prague, Czech Republic
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands

    Nanotechnology approach in tuberculosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in